Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.10
-0.20 (-0.29%)
At close: May 28, 2026

TPEX:7871 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-1,107-440.32268.21
Depreciation & Amortization
9.187.353.76
Loss (Gain) From Sale of Assets
--0.02-
Loss (Gain) on Equity Investments
-9.670.31-
Stock-Based Compensation
2.54.021.71
Other Operating Activities
942.49226.55-372.17
Change in Accounts Receivable
7.17-3.29-1.68
Change in Accounts Payable
26.67-33.664.98
Change in Unearned Revenue
---9.83
Change in Other Net Operating Assets
-3.81-0.65-0.32
Operating Cash Flow
-131.97-239.7-105.33
Capital Expenditures
-0.5-9.97-0.22
Sale of Property, Plant & Equipment
-0.02-
Sale (Purchase) of Intangibles
-5--
Investment in Securities
---0.29
Other Investing Activities
0.060.610.02
Investing Cash Flow
-5.44-9.34-0.49
Short-Term Debt Issued
634.6309.461.01
Total Debt Issued
634.6309.461.01
Long-Term Debt Repaid
-10.66-11-1.08
Net Debt Issued (Repaid)
623.95298.459.93
Issuance of Common Stock
247.161.651.91
Financing Cash Flow
871.1300.0561.83
Foreign Exchange Rate Adjustments
41.556.570.97
Net Cash Flow
775.2457.59-43.02
Free Cash Flow
-132.48-249.67-105.55
Free Cash Flow Margin
-263.44%-31091.78%-410.76%
Free Cash Flow Per Share
-1.68-11.28-1.32
Cash Interest Paid
-1.310.5
Levered Free Cash Flow
-80.8-176.75-
Unlevered Free Cash Flow
-80.2-175.93-
Change in Working Capital
30.03-37.59-6.85